Cyclophosphamide: Febrile neutropenia, granulomatous hepatitis and fatal liver failure in an elderly patient?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1276, 2009-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Liposomal Amphotericin B versus Voriconazole for Empirical Treatment of Febrile Neutropenia

By Collins Curtis D.   Stuntebeck Emily R.   DePestel Daryl D.   Stevenson James G.  

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 233-241

Adis International

Access to resources Recommend Favorite

Clinical and Economic Considerations of Empirical Antibacterial Therapy of Febrile Neutropenia in Cancer

By Dranitsaris G.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 343-353

Adis International

Access to resources Recommend Favorite

Myeloid Growth Factor Therapy for Prophylaxis of Febrile Neutropenia in Non-Myeloid Malignancies: Appropriate Doses and Schedules

By Althaus Betsy L.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 2, 2007-02 ,pp. : 229-234

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections

By Moen Marit D.   Lyseng-Williamson Katherine A.   Scott Lesley J.  

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 361-392

Adis International

Access to resources Recommend Favorite